Stock Events

Direxion Daily S&P Biotech Bull 3X Shares 

M$2,547
151
+M$45+1.8% Tuesday 19:47

Statistics

Day High
2,560
Day Low
2,391.91
52W High
3,000
52W Low
898.2
Volume
149
Avg. Volume
525
Mkt Cap
-
P/E Ratio
-
Dividend Yield
0.38%
Dividend
9.68

Upcoming

24
SEP
Dividend Ex
Estimated
 
1
OCT
Dividend Payment
Estimated
 
23
DEC
Dividend Ex
Estimated
 
31
DEC
Dividend Payment
Estimated
 
19
MAR 25
Dividend Ex
Estimated
 
26
MAR 25
Dividend Payment
Estimated
 
25
JUN 25
Dividend Ex
Estimated
 
2
JUL 25
Dividend Payment
Estimated
 
19
SEP 25
Dividend Ex
Estimated
 
26
SEP 25
Dividend Payment
Estimated
 

Dividends

0.38%Dividend Yield
Oct 24
M$0.69
Jul 24
M$2.72
Mar 24
M$2.7
Dec 23
M$3.57
Sep 23
M$0.69
10Y Growth
N/A
5Y Growth
-31.1%
3Y Growth
N/A
1Y Growth
33.82%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LABU.MX. It's not an investment recommendation.
Alphabet
73169
GOOGL
Apple
63935
AAPL
Microsoft
59591
MSFT
Amazon
55012
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Direxion Daily S&P Biotech Bear 3X Shares
LABD
Mkt Cap0
Direxion Daily S&P Biotech Bear 3X Shares, the inverse ETF of LABU, offering 3X leveraged exposure in the opposite direction.
ProShares Ultra Nasdaq Biotechnology 2X Shares
BIB
Mkt Cap0
ProShares Ultra Nasdaq Biotechnology, a 2X leveraged ETF focusing on the biotech sector, similar to LABU but with less leverage.
ProShares UltraShort Nasdaq Biotechnology -2x Shares
BIS
Mkt Cap0
ProShares UltraShort Nasdaq Biotechnology, offers 2X leveraged inverse exposure to the biotech sector, competing with LABU's bear counterpart.
SPDR Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF, a non-leveraged ETF that tracks the biotech sector, competing for the same investor base as LABU.
iShares Biotechnology
IBB
Mkt Cap0
iShares Nasdaq Biotechnology ETF, another major non-leveraged biotech ETF, competing in the biotech investment space with LABU.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, offers exposure to the biotech industry, competing with LABU for biotech-focused investments.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund, a non-leveraged ETF competing in the biotech sector investment space.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF, focuses on smaller companies in the biotech sector, offering a different approach but still competing for biotech investors.
ARK Genomic Revolution
ARKG
Mkt Cap0
ARK Genomic Revolution ETF, focuses on genomics and biotech, competing with LABU by targeting innovation in the biotech space.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF, offers exposure to the biotech and genomic sector, competing for similar investment interests.

About

The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Show more...
CEO
Country
US
ISIN
US25460G1206

Listings

ARCX
US
LABU
MX
MX
LABU.MX